Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:genus
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Toni_Wine
|
| gptkbp:can_lead_to |
systemic infections
|
| gptkbp:caused_by |
candidiasis
invasive candidiasis oral thrush vaginal yeast infections |
| gptkbp:communication |
direct contact
|
| gptkbp:established |
probiotics
|
| https://www.w3.org/2000/01/rdf-schema#label |
Candida
|
| gptkbp:is_a |
gptkb:fungus
|
| gptkbp:is_affected_by |
gptkb:product
hormonal changes p H levels |
| gptkbp:is_associated_with |
gptkb:hospital
hospital-acquired infections neutropenia immunocompromised patients biofilm-related infections long-term catheter use |
| gptkbp:is_found_in |
gptkb:Person
|
| gptkbp:is_involved_in |
immune response
nutrient absorption |
| gptkbp:is_linked_to |
gptkb:Company
chronic diseases obesity respiratory infections skin infections antibiotic use gastrointestinal infections |
| gptkbp:is_monitored_by |
gptkb:hospital
|
| gptkbp:is_often_depicted_as |
mucosal surfaces
|
| gptkbp:is_often_used_in |
hospital settings
pregnant women elderly patients newborns people with obesity people with diabetes people with HIV/ AIDS people with cancer immunosuppressed individuals people on antibiotics |
| gptkbp:is_part_of |
normal flora
microbiota yeast family |
| gptkbp:is_recognized_by |
culture tests
molecular methods |
| gptkbp:is_studied_in |
mycology
vaccine development biofilm formation pathogenicity diagnostic methods antifungal resistance |
| gptkbp:is_vulnerable_to |
some antifungal agents
|
| gptkbp:sensor |
antifungal medications
|
| gptkbp:treatment |
gptkb:amphotericin_B
gptkb:fluconazole echinocandins intravenous antifungals oral antifungals topical antifungals |